Kayne Anderson Rudnick Investment Management LLC Sells 26,149 Shares of National Research Co. (NASDAQ:NRC)

Kayne Anderson Rudnick Investment Management LLC decreased its holdings in National Research Co. (NASDAQ:NRC - Free Report) by 0.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,033,427 shares of the company's stock after selling 26,149 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned about 12.92% of National Research worth $53,510,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. PNC Financial Services Group Inc. increased its position in National Research by 2,250.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 1,528 shares of the company's stock worth $27,000 after buying an additional 1,463 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in shares of National Research in the fourth quarter valued at approximately $50,000. FMR LLC grew its position in National Research by 397.3% during the third quarter. FMR LLC now owns 2,944 shares of the company's stock worth $67,000 after buying an additional 2,352 shares in the last quarter. Signaturefd LLC increased its stake in National Research by 613.3% during the 4th quarter. Signaturefd LLC now owns 4,173 shares of the company's stock worth $74,000 after acquiring an additional 3,588 shares during the period. Finally, Quadrant Capital Group LLC lifted its position in shares of National Research by 219.3% during the 4th quarter. Quadrant Capital Group LLC now owns 5,006 shares of the company's stock valued at $88,000 after acquiring an additional 3,438 shares during the period. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Price Performance

Shares of NASDAQ NRC traded up $0.06 during mid-day trading on Thursday, reaching $10.69. The company had a trading volume of 65,146 shares, compared to its average volume of 93,585. The firm has a market cap of $245.29 million, a price-to-earnings ratio of 10.18 and a beta of 0.41. The business's 50-day simple moving average is $13.47 and its 200 day simple moving average is $16.62. National Research Co. has a one year low of $9.76 and a one year high of $35.81. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47.

National Research (NASDAQ:NRC - Get Free Report) last issued its earnings results on Monday, January 27th. The company reported $0.28 EPS for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were paid a $0.12 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.49%. National Research's payout ratio is currently 45.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.